Association between CYP1A1 2454A > G polymorphism and colorectal cancer risk: A meta-analysis

被引:4
作者
Xu, Liang [1 ]
Wei, Hongwei [1 ]
机构
[1] Gen Hosp Liaohe Oil Field, Dept Oncol, 26 Ying Bin St, Panjin City 124010, Liaoning, Peoples R China
关键词
Colorectal cancer; CYP1A1 2454A > G; meta-analysis; polymorphism; XENOBIOTIC-METABOLIZING ENZYMES; GENETIC POLYMORPHISMS; CYTOCHROME-P450; 1A1; SUSCEPTIBILITY; GSTM1; ILE462VAL; DISEASE; GSTT1; NAT2; 2E1;
D O I
10.4103/0973-1482.160909
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The aim of our study was to assess the association of CYP1A1 2454A > G polymorphism and colorectal cancer (CRC) risk. Materials and Methods: Electronic databases, including PubMed, MEDLINE Springer, Elsevier Science Direct, Cochrane Library, and Google Scholar were searched for relevant trials until December 2013. Pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated to assess the strength of the association. Subgroup analyses were conducted based on geographical region and size of the study samples. Results: Thirteen eligible studies were included in this meta-analysis with 3490 cases and 4076 controls. There were significant associations under the overall ORs for G-allele comparison (G vs. A, pooled OR 1.29, 95% CI 1.03-1.61, P = 0.03), GG versus AA comparison (pooled OR 1.50, 95% CI 1.17-1.91, P < 0.01), recessive model (GG vs. GA AA, pooled OR 1.52, 95% CI 1.20-1.94, P < 0.01) between CYP1A1 2454A > G polymorphism and CRC risk. Subgroup analyses stratified by geographical region demonstrated an association in Asia and Europe, but not in America. Conclusion : This meta-analysis suggests that CYP1A1 2454A > G polymorphism might be associated with susceptibility of CRC and the allele G might increase the CRC risk in Asia and Europe.
引用
收藏
页码:760 / 764
页数:5
相关论文
共 30 条
[1]  
Bartsch H, 2000, CANCER EPIDEM BIOMAR, V9, P3
[2]   The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies [J].
Chen, Zhiwei ;
Li, Ziming ;
Niu, Xiaomin ;
Ye, Xiangyun ;
Yu, Yongfeng ;
Lu, Shun ;
Chen, Zhen .
MUTAGENESIS, 2011, 26 (03) :437-446
[3]  
Deeks J.J., 2008, Systematic Reviews in Health Care: Meta-Analysis in Context, Second Edition, P285, DOI DOI 10.1002/9780470693926.CH15
[4]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[5]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[6]   Molecular Genetics of Colorectal Cancer [J].
Fearon, Eric R. .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6, 2011, 6 :479-+
[7]   Detection of cytochrome P4501B1 Bfr I polymorphism:: genotype distribution in healthy German individuals and in patients with colorectal carcinoma [J].
Fritsche, E ;
Brüning, T ;
Jonkmanns, C ;
Ko, Y ;
Bolt, HM ;
Abel, J .
PHARMACOGENETICS, 1999, 9 (03) :405-408
[8]   Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies [J].
Gong, Feng-Feng ;
Lu, Shan-Shan ;
Hu, Cai-Yun ;
Qian, Zhen-Zhong ;
Feng, Fang ;
Wu, Yi-Le ;
Yang, Hui-Yun ;
Sun, Ye-Huan .
TUMOR BIOLOGY, 2014, 35 (10) :10351-10361
[9]   Measuring inconsistency in meta-analyses [J].
Higgins, JPT ;
Thompson, SG ;
Deeks, JJ ;
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7414) :557-560
[10]  
Ishibe N, 2000, CANCER EPIDEM BIOMAR, V9, P855